Real world aspects of palliative trifluridine plus tiperacil (TAS-102) in refractory metastatic colorectal cancer

Wallander, M; Rolander, B; Avall-Lundqvist, E; Elander, NO

Elander, NO (corresponding author), Linkoping Univ, SE-58185 Linkoping, Sweden.

JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2020; 11 (4): 616

Abstract

Background: While recent randomised phase III trials show that trifluridine/tiperacil (TAS-102) may prolong life in patients with refractory metastati......

Full Text Link